BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 36973567)

  • 41. [Safety and prognosis analysis of transanal total mesorectal excision versus laparoscopic mesorectal excision for mid-low rectal cancer].
    Sun R; Cong L; Qiu HZ; Lin GL; Wu B; Niu BZ; Sun XY; Zhou JL; Xu L; Lu JY; Xiao Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jun; 25(6):522-530. PubMed ID: 35754217
    [No Abstract]   [Full Text] [Related]  

  • 42. Lateral lymph node dissection with radical surgery versus single radical surgery for rectal cancer: a meta-analysis.
    Cheng H; Deng Z; Wang ZJ; Zhang W; Su JT
    Asian Pac J Cancer Prev; 2011; 12(10):2517-21. PubMed ID: 22320950
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mesorectal Excision With or Without Lateral Lymph Node Dissection for Clinical Stage II/III Lower Rectal Cancer (JCOG0212): A Multicenter, Randomized Controlled, Noninferiority Trial.
    Fujita S; Mizusawa J; Kanemitsu Y; Ito M; Kinugasa Y; Komori K; Ohue M; Ota M; Akazai Y; Shiozawa M; Yamaguchi T; Bandou H; Katsumata K; Murata K; Akagi Y; Takiguchi N; Saida Y; Nakamura K; Fukuda H; Akasu T; Moriya Y;
    Ann Surg; 2017 Aug; 266(2):201-207. PubMed ID: 28288057
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lateral pelvic sentinel lymph node biopsy using indocyanine green fluorescence navigation: can it be a powerful supplement tool for predicting the status of lateral pelvic lymph nodes in advanced lower rectal cancer.
    Su H; Xu Z; Bao M; Luo S; Liang J; Pei W; Guan X; Liu Z; Jiang Z; Zhang M; Zhao Z; Jin W; Zhou H
    Surg Endosc; 2023 May; 37(5):4088-4096. PubMed ID: 36997652
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term follow-up of the randomized trial of mesorectal excision with or without lateral lymph node dissection in rectal cancer (JCOG0212).
    Tsukamoto S; Fujita S; Ota M; Mizusawa J; Shida D; Kanemitsu Y; Ito M; Shiomi A; Komori K; Ohue M; Akazai Y; Shiozawa M; Yamaguchi T; Bando H; Tsuchida A; Okamura S; Akagi Y; Takiguchi N; Saida Y; Akasu T; Moriya Y;
    Br J Surg; 2020 Apr; 107(5):586-594. PubMed ID: 32162301
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mesorectal excision with or without lateral lymph node dissection for elderly patients with mid-low rectal cancer: safety and feasibility analysis.
    Zhou S; Mei S; Feng B; Yang Y; Wang X; Wang Q; Liu Q;
    Jpn J Clin Oncol; 2023 Jan; 53(1):26-34. PubMed ID: 36354102
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Open versus laparoscopic lateral lymph node dissection for mid- and low- rectal cancer: a propensity score matching study.
    Zhang Y; Yang X; Wang D; Zhuang Z; Wei M; Meng W; Deng X; Wang Z
    ANZ J Surg; 2021 Nov; 91(11):2487-2492. PubMed ID: 34664380
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of laparoscopic lateral lymph node dissection for rectal cancer with and without routine resection of the visceral branches of internal iliac artery.
    Xiao J; Zhang X; Gu C; Yang X; Meng W; Wei M; Wang Z
    J Surg Oncol; 2024 Feb; 129(2):308-316. PubMed ID: 37849371
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lateral Nodal Features on Restaging Magnetic Resonance Imaging Associated With Lateral Local Recurrence in Low Rectal Cancer After Neoadjuvant Chemoradiotherapy or Radiotherapy.
    Ogura A; Konishi T; Beets GL; Cunningham C; Garcia-Aguilar J; Iversen H; Toda S; Lee IK; Lee HX; Uehara K; Lee P; Putter H; van de Velde CJH; Rutten HJT; Tuynman JB; Kusters M;
    JAMA Surg; 2019 Sep; 154(9):e192172. PubMed ID: 31268504
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Concept of lateral lymph nodes in rectal cancer and controversy over lateral lymph node dissection].
    An K; Gu J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Aug; 25(8):694-698. PubMed ID: 35970803
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The efficacy and safety of lateral lymph node dissection for patients with rectal cancer: A systematic review and meta-analysis.
    Ma P; Yuan Y; Yan P; Chen G; Ma S; Niu X; Xu M; Yang K; Cai H
    Asian J Surg; 2020 Sep; 43(9):891-901. PubMed ID: 31926817
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical influence of prophylactic lateral lymph node dissection on oncologic outcomes of patients with mid-low rectal cancer undergoing mesorectal excision: a meta-analysis.
    Ishizuka M; Shibuya N; Hachiya H; Nishi Y; Takayanagi M; Fujita J; Ihara K; Shiraki T; Matsumoto T; Mori S; Iso Y; Nakamura T; Aoki T; Irisawa A
    J Gastrointest Surg; 2024 Apr; 28(4):548-558. PubMed ID: 38583909
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Robotic pelvic side-wall dissection and en-bloc excision for locally advanced and recurrent rectal cancer: outcomes on feasibility and safety.
    Lokuhetty N; Larach JT; Rajkomar AKS; Mohan H; Waters PS; Heriot AG; Warrier SK
    ANZ J Surg; 2022 Sep; 92(9):2185-2191. PubMed ID: 35555959
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Application value of fascia orientation in lateral lymph node dissection of low rectal cancer].
    Liu Q; Wang XS
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 May; 22(5):432-435. PubMed ID: 31104427
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Total mesorectal excision with and without lateral lymph node dissection: a systematic review of the literature.
    Longchamp G; Meyer J; Christou N; Popeskou S; Roos E; Toso C; Buchs NC; Ris F
    Int J Colorectal Dis; 2020 Jul; 35(7):1183-1192. PubMed ID: 32458399
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Laparoscopic Versus Open Lateral Lymph Node Dissection for Locally Advanced Low Rectal Cancer: A Subgroup Analysis of a Large Multicenter Cohort Study in Japan.
    Yamaguchi T; Konishi T; Kinugasa Y; Yamamoto S; Akiyoshi T; Okamura R; Ito M; Nishimura Y; Shiozawa M; Yamaguchi S; Hida K; Sakai Y; Watanabe M
    Dis Colon Rectum; 2017 Sep; 60(9):954-964. PubMed ID: 28796734
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Beyond transanal total mesorectal excision: short-term outcomes of transanal total mesorectal excision in locally advanced rectal cancer requiring resection beyond total mesorectal excision.
    Larach JT; Rajkomar AKS; Smart PJ; McCormick JJ; Heriot AG; Warrier SK
    Colorectal Dis; 2021 Apr; 23(4):823-833. PubMed ID: 33217140
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Two-Team Transanal Total Mesorectal Excision and En Bloc Resection of the Lateral Pelvic Lymph Nodes, Main Iliac Vessels, and Pelvic Plexus for Locally Advanced Rectal Cancer With Lateral Lymph Node Metastasis.
    Shioi I; Ogawa H; Hosoi N; Yamaguchi A; Watanabe T; Nakazawa N; Shibasaki Y; Shiraishi T; Osone K; Okada T; Sano A; Sakai M; Sohda M; Shirabe K; Saeki H
    Surg Laparosc Endosc Percutan Tech; 2024 Apr; 34(2):237-241. PubMed ID: 38421177
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Outcomes of Total Mesorectal Excision and Lateral Lymph Node Dissection following Neoadjuvant Chemotherapy for Lower Rectal Cancer with Lateral Lymph Node Metastasis].
    Morohashi H; Uchida C; Ogasawara H; Hara Y; Akaishi T; Yachi T; Wakasa Y; Mitsuhashi Y; Tsuruta S; Sato K; Yoshida T; Umetsu S; Hasebe T; Suto A; Hakamada K
    Gan To Kagaku Ryoho; 2018 Dec; 45(13):1803-1805. PubMed ID: 30692359
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Standardized comparison of robot-assisted limited and extended pelvic lymphadenectomy for prostate cancer.
    Yuh BE; Ruel NH; Mejia R; Novara G; Wilson TG
    BJU Int; 2013 Jul; 112(1):81-8. PubMed ID: 23351148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.